Your Health Plan:
RIABNI (rituximab) is a biosimilar prescription drug for treatment of Rheumatoid Arthritis, Granulomatosis with polyangiitis and Microscopic Polyarteritis. RIABNI is a cd20-directed cytolytic antibody. It is available in the form of intravenous injection.
See full Prescribing Information for important safety information and clinical studies.
RIABNI is not covered by . Cash price for 30-day supply is $600-3900.
Patient Assistance Prorgams and Coupons are found: